Exploring ESA Treatment Outcomes in Lower-Risk MDS: Expert Perspectives

Thomas LeBlanc, MD, MA, of the Duke Cancer Institute, moderates a discussion with Andrew Brunner, MD of Massachusetts General Hospital, and Jamie Koprivnikar, MD, of Hackensack University Medical Center, about findings from a Florida Cancer Specialists study on managing lower-risk MDS. Explore real-world outcomes post-ESA treatment in community oncology settings.